emodin
We       demonstrated previously that emodin, a tyrosine kinase inhibitor, suppresses       tyrosine kinase activity in HER-2/neu-overexpressing breast cancer cells and       preferentially represses transformation phenotypes of these cells in vitro.
We       demonstrated previously that  @SUBJECT$  @PREDICAT$  @OBJECT$ , suppresses       tyrosine kinase activity in HER-2/neu-overexpressing breast cancer cells and       preferentially represses transformation phenotypes of these cells in vitro.